Anxiolytic-like and antinociceptive activities of the noncompetitive NMDA receptor antagonist MK-801 (dizocilpine) were compared with sedative and ataxic side effects in primates. Administration of MK-801 (0.1 mg/kg) caused taming in cynomolgus monkeys and increased tail withdrawal latencies in squirrel monkeys; both effects were accompanied by sedation and ataxia. These findings are discussed in relation to the possible therapeutic uses of NMDA antagonists and differences in the behavioural effects of such compounds in primate and rodent species
Dizocilpine (MK-801) is a non-competitive NMDA antagonist that induces schizophreniclike effects. It...
Although the antinociceptive effect of NMDA antagonists in the formalin test is well recognised, the...
The competitive excitatory amino acid antagonist cis-4-phosphonomethyl-2-piperidine-carboxylic acid ...
Anxiolytic-like and antinociceptive activities of the noncompetitive NMDA receptor antagonist MK-801...
The antianxiety effect of the non-competitive NMDA receptor antagonist, MK-801, was investigated in ...
This paper reports biochemical and behavioural experiments, planned to obtain a deeper knowledge on ...
MK-801, also called dizocilpine, is an N-methyl-D-aspartate (NMDA) receptor antagonist widely used i...
Dissociable antidepressant-like and abuse-related effects of the noncompetitive NMDA receptor antago...
The complex pathophysiology of brain disorders and the difficulty of delivering therapeutic agents t...
We have compared the ability of phencyclidine (PCP)-like or sigma ligands to induce psychomotor effe...
Antianxiety effect of noncompetitive NMDA receptor antagonist MK 801 was investigated on elevated pl...
We examined whether the N-methyl-D-aspartate antagonist MK-801 (dizocilpine) would reverse parkinson...
One of the most studied neurotransmitter systems in addiction is the mesolimbic dopamine pathway, wh...
The effects of pretreatment with the non-competitive NMDA antagonist (+)MK-801 on the behavioral alt...
Increasing evidence indicates that sleep deprivation alters behavioural responses to various pharmac...
Dizocilpine (MK-801) is a non-competitive NMDA antagonist that induces schizophreniclike effects. It...
Although the antinociceptive effect of NMDA antagonists in the formalin test is well recognised, the...
The competitive excitatory amino acid antagonist cis-4-phosphonomethyl-2-piperidine-carboxylic acid ...
Anxiolytic-like and antinociceptive activities of the noncompetitive NMDA receptor antagonist MK-801...
The antianxiety effect of the non-competitive NMDA receptor antagonist, MK-801, was investigated in ...
This paper reports biochemical and behavioural experiments, planned to obtain a deeper knowledge on ...
MK-801, also called dizocilpine, is an N-methyl-D-aspartate (NMDA) receptor antagonist widely used i...
Dissociable antidepressant-like and abuse-related effects of the noncompetitive NMDA receptor antago...
The complex pathophysiology of brain disorders and the difficulty of delivering therapeutic agents t...
We have compared the ability of phencyclidine (PCP)-like or sigma ligands to induce psychomotor effe...
Antianxiety effect of noncompetitive NMDA receptor antagonist MK 801 was investigated on elevated pl...
We examined whether the N-methyl-D-aspartate antagonist MK-801 (dizocilpine) would reverse parkinson...
One of the most studied neurotransmitter systems in addiction is the mesolimbic dopamine pathway, wh...
The effects of pretreatment with the non-competitive NMDA antagonist (+)MK-801 on the behavioral alt...
Increasing evidence indicates that sleep deprivation alters behavioural responses to various pharmac...
Dizocilpine (MK-801) is a non-competitive NMDA antagonist that induces schizophreniclike effects. It...
Although the antinociceptive effect of NMDA antagonists in the formalin test is well recognised, the...
The competitive excitatory amino acid antagonist cis-4-phosphonomethyl-2-piperidine-carboxylic acid ...